Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Maggi

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Annals of Hematology|April 21, 2018
Ponatinib as second-line treatment in chronic phase chronic myeloid leukemia patients in real-life practiceMassimo Breccia, Elisabetta Abruzzese, Fausto Castagnetti, et al.
Annals of Hematology|January 16, 2023
A real-world analysis of PD1 blockade from the Rete Ematologica Pugliese (REP) in patients with relapse/refractory Hodgkin's lymphomaFrancesco Gaudio, Giacomo Loseto, Valentina Bozzoli, et al.
Bone Marrow Transplantation|May 27, 2026
Outcomes of mixed phenotype acute leukemia undergoing allogeneic stem cell transplantation: a retrospective study of the ALWP of EBMTAnnalisa Paviglianiti, Maud Ngoya, Regis Peffault de la Tour, et al.
Frontiers in Oncology|June 14, 2021
Perspectives and Emotional Experiences of Patients With Chronic Myeloid Leukemia During ENESTPath Clinical Trial and Treatment-Free Remission: Rationale and Protocol of the Italian SubstudyLidia Borghi, Gianantonio Rosti, Alessandro Maggi, et al.
Frontiers in Oncology|March 21, 2022
Treatment-Free Remission in Chronic Myeloid Leukemia Patients Treated With Low-Dose TKIs: A Feasible Option Also in the Real-Life. A Campus CML StudyAlessandra Iurlo, Daniele Cattaneo, Silvia Artuso, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 5, 2016
Personal history and quality of life in chronic myeloid leukemia patients: a cross-sectional study using narrative medicine and quantitative analysisMassimo Breccia, Guendalina Graffigna, Sara Galimberti, et al.
Annals of Hematology|May 28, 2024
Daratumumab-based regimens for patients with multiple myeloma plus extramedullary plasmacytomas or paraskeletal plasmacytomas: initial follow-up of an Italian multicenter observational clinical experienceGiuseppe Mele, Daniele Derudas, Concetta Conticello, et al.
Leukemia Research|December 9, 2015
Dasatinib first-line: Multicentric Italian experience outside clinical trialsMassimo Breccia, Fabio Stagno, Luigiana Luciano, et al.
Annals of Hematology|January 11, 2026
Hypomethylating agents alone or in combination with venetoclax in very elderly acute myeloid leukemia patients: less treatment, better care?Francesco Tarantini, Corinne Contento, Ernesto Vigna, et al.
Cancers|May 27, 2026
Assessment of Transitioning from High-Potency to Low-Potency Inhibitors in Chronic Myeloid Leukemia (CML) Patients: The Downgrading-Impact (D-IMPACT) ProjectElisabetta Abruzzese, Monica Crugnola, Luca Garuffo, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Annals of Hematology|April 21, 2018
Ponatinib as second-line treatment in chronic phase chronic myeloid leukemia patients in real-life practiceMassimo Breccia, Elisabetta Abruzzese, Fausto Castagnetti, et al.
Annals of Hematology|January 16, 2023
A real-world analysis of PD1 blockade from the Rete Ematologica Pugliese (REP) in patients with relapse/refractory Hodgkin's lymphomaFrancesco Gaudio, Giacomo Loseto, Valentina Bozzoli, et al.
Bone Marrow Transplantation|May 27, 2026
Outcomes of mixed phenotype acute leukemia undergoing allogeneic stem cell transplantation: a retrospective study of the ALWP of EBMTAnnalisa Paviglianiti, Maud Ngoya, Regis Peffault de la Tour, et al.
Frontiers in Oncology|June 14, 2021
Perspectives and Emotional Experiences of Patients With Chronic Myeloid Leukemia During ENESTPath Clinical Trial and Treatment-Free Remission: Rationale and Protocol of the Italian SubstudyLidia Borghi, Gianantonio Rosti, Alessandro Maggi, et al.
Frontiers in Oncology|March 21, 2022
Treatment-Free Remission in Chronic Myeloid Leukemia Patients Treated With Low-Dose TKIs: A Feasible Option Also in the Real-Life. A Campus CML StudyAlessandra Iurlo, Daniele Cattaneo, Silvia Artuso, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 5, 2016
Personal history and quality of life in chronic myeloid leukemia patients: a cross-sectional study using narrative medicine and quantitative analysisMassimo Breccia, Guendalina Graffigna, Sara Galimberti, et al.
Annals of Hematology|May 28, 2024
Daratumumab-based regimens for patients with multiple myeloma plus extramedullary plasmacytomas or paraskeletal plasmacytomas: initial follow-up of an Italian multicenter observational clinical experienceGiuseppe Mele, Daniele Derudas, Concetta Conticello, et al.
Leukemia Research|December 9, 2015
Dasatinib first-line: Multicentric Italian experience outside clinical trialsMassimo Breccia, Fabio Stagno, Luigiana Luciano, et al.
Annals of Hematology|January 11, 2026
Hypomethylating agents alone or in combination with venetoclax in very elderly acute myeloid leukemia patients: less treatment, better care?Francesco Tarantini, Corinne Contento, Ernesto Vigna, et al.
Cancers|May 27, 2026
Assessment of Transitioning from High-Potency to Low-Potency Inhibitors in Chronic Myeloid Leukemia (CML) Patients: The Downgrading-Impact (D-IMPACT) ProjectElisabetta Abruzzese, Monica Crugnola, Luca Garuffo, et al.
Pageof 3